These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16476659)

  • 1. Dopamine receptor excess and mouse madness.
    Snyder SH
    Neuron; 2006 Feb; 49(4):484-5. PubMed ID: 16476659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling excess striatal D2 receptors in mice.
    Kellendonk C
    Prog Brain Res; 2009; 179():59-65. PubMed ID: 20302818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.
    Kellendonk C; Simpson EH; Polan HJ; Malleret G; Vronskaya S; Winiger V; Moore H; Kandel ER
    Neuron; 2006 Feb; 49(4):603-15. PubMed ID: 16476668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
    Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention.
    Glickstein SB; Desteno DA; Hof PR; Schmauss C
    Cereb Cortex; 2005 Jul; 15(7):1016-24. PubMed ID: 15537671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
    Di Pietro NC; Seamans JK
    Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis pathways converge via D2high dopamine receptors.
    Seeman P; Schwarz J; Chen JF; Szechtman H; Perreault M; McKnight GS; Roder JC; Quirion R; Boksa P; Srivastava LK; Yanai K; Weinshenker D; Sumiyoshi T
    Synapse; 2006 Sep; 60(4):319-46. PubMed ID: 16786561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO.
    Seeman P; Battaglia G; Corti C; Corsi M; Bruno V
    Synapse; 2009 Mar; 63(3):247-51. PubMed ID: 19084908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.
    Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG
    Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontal cortex lesions eliminate the clock speed effect of dopaminergic drugs on interval timing.
    Meck WH
    Brain Res; 2006 Sep; 1108(1):157-67. PubMed ID: 16844101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum.
    Minzer K; Lee O; Hong JJ; Singer HS
    J Neurol Sci; 2004 Apr; 219(1-2):55-61. PubMed ID: 15050438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine D2 binding is related to frontal BOLD response during updating of long-term memory representations.
    Nyberg L; Andersson M; Forsgren L; Jakobsson-Mo S; Larsson A; Marklund P; Nilsson LG; Riklund K; Bäckman L
    Neuroimage; 2009 Jul; 46(4):1194-9. PubMed ID: 19327403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
    Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) > D(2) antagonist, S33138.
    Millan MJ; Brocco M
    Therapie; 2008; 63(3):187-229. PubMed ID: 18718210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational model of the functional role of the ventral-striatal D2 receptor in the expression of previously acquired behaviors.
    Smith AJ; Becker S; Kapur S
    Neural Comput; 2005 Feb; 17(2):361-95. PubMed ID: 15720772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
    J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.